Do you remember when you joined X? I do! #MyXAnniversary

Nice work by @EliLillyandCo on their #Olympics message: youtu.be/2paOxynX7aQ?si=hLKN…

Did you ever wonder if cardiologists around the world are still active on X/Twitter? They are. Contact us at [email protected] for more information! bit.ly/3XS3g5c

It's amazing how much of an impact the GLP-1s are already having ... Novo, Lilly buoyed by fast-growing GLP-1 drug sales buff.ly/45TZDfj by @byjongardner

Nice work from the people at @Boehringer | Boehringer Ingelheim pledges ‘Life forward’ with new corporate branding buff.ly/3FG7dj6 by @bethsbulik via @endpts

I just compared the number of physicians who've posted on twitter between Jan 1 and Sep 30 for 2022 and 2023. The number has dropped less than 5%! In spite of its issues, #MedTwitter still lives on!

This is a big deal - congrats to @sanofi and @astrazeneca! FDA approves Sanofi-AstraZeneca's preventive RSV therapy for children buff.ly/3NVo7Ot via @mmmnews

Particularly interesting insights from @brianreid's "Cost Curve" newsletter on @EliLillyandCo Mounjaro pricing model | Late-Breaking News (PhRMA Sues Over the IRA) Means a Late Curve buff.ly/42QHuh8

Great move from @abbvie. I follow Dex on his socials and have seen multiple posts already. | AbbVie calls up World Series champion Dexter Fowler for IBD initiative buff.ly/3X9MFqY

We still believe in twitter, but if Musk continues to lead based on his whim of the moment, it's going to get worse b4 it gets better. ‘Not knowing what’s coming next is a big question mark’: Twitter, Elon Musk and pharma’s uneasy detente buff.ly/3EmMEqD @Marc_Iskowitz

Hmm. I wonder if this is a "feature" of the act or an unintended consequence? Alnylam blames the Inflation Reduction Act for a PhIII cut — would it have sold enough for negotiations? buff.ly/3sydXJk

This is encouraging! #PharmaTok: Amgen, AZ join growing number of pharma marketers on the social video channel buff.ly/3rL39a6 by @BethSBulik #PharmaMarketing